We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
AgPlus has created a diagnostic platform for detecting human diseases and delivering laboratory instrument results instantly, whilst keeping in mind the business requirements and unmet requirements. The company works in collaboration with leading diagnostics companies to improve and share products quickly and globally. It aims is to become known as a leader in Point of Care diagnosis.
days to go: Expired investment: £65,004
Ablatus Therapeutics is a MedTech company developing a one-of-a-kind tissue ablation platform known as Bimodal Electric Tissue Ablation (BETA). This technology has been designed to overcome the limitations of existing products by offering ablation solutions in oncology (tumours) as well as non-oncology targets. With the proceeds, the company will finish the final elements of engineering of the generator and probe. It will also deliver formal safety test data that is a prerequisite for subsequent clinical trials.
days to go: Expired investment: Withheld
Active Food Systems, trading as Synergy Grill, has developed and patented innovative and commercial cooking technology for the food and hospitality industry. Its ‘Fat Atomising Grill' makes cleaning quick and easy while delivering cost savings through a 59% reduction in fuel consumption. The company has sold 2000+ units of the grill to entities like Whitbread, Greene King, Marriott, Radisson and Marstons among others. Synergy Grill asserts that its performance in the first half of the year has been profitable despite COVID-19. They have contracts with reputed organisations like Whitbread and Marstons have generated revenues of £970,000. The company is in conversation with over 50 pubs and restaurants including product trials with Nandos, Weatherspoons and Mitchell Butler that are interested in its product. It will use the investment to grow its business across different verticals.
days to go: Expired investment: £316,488
Antev Limited (Antev) is a clinical-stage biopharmaceutical firm which focuses on the evolution of a drug used for prostate cancer, Teverelix TFA. The company is working on growing its copyright protection and is currently developing phase IIb clinical plans for prostate cancer. Antev is a pre-revenue company that aims at increasing its shareholder value by progressing the development of teverelix TFA towards registration whose approval is anticipated from 2023 onwards. The proceeds will be used for production, IP development, working capital and to develop a phase IIb repeat dosing clinical trial in prostate cancer.
days to go: Expired investment: Withheld
Arca have introduced new tools for property risk management and created a marketplace to trade portfolio risks to match buyers and sellers of financial products connected to the performance of real estate. They are opening up the concept of short term property market risk management for property portfolio managers.  
days to go: Expired investment: £575,000
Aveqia is a unique interactive gastronomic experience combining a luxury restaurant with state of the art kitchens to create an exceptional venue for corporate events or private groups. These experiences are run by Michelin star trained chefs.
days to go: Expired investment: £100,000
Aveqia London is a unique interactive gastronomic experience combining a luxury restaurant with state of the art kitchens to create an exceptional venue for corporate events or private groups. Aveqia gives clients or colleagues the opportunity to work together to prepare and consume cuisine.
days to go: Expired investment: £100,000
Brands reunited are looking to disrupt the modern craft beer market. Their sales are over £400k and are growing 100% year on year. They have two brands that are already in Watneys and Home Ales. The funding will be spent on building their brand and the team. 
days to go: Expired investment: £255,000
Caldera is a heat battery company that seeks to institutionalise zero-carbon energy solutions for the masses. It asserts that its 'Zero Carbon Boiler' is a direct replacement to an oil or gas boiler by providing low-cost renewable electricity as heat for later use on demand by the homeowner. The company asserts that the boiler consists of two elements. The first is Caldera's proprietary 'Warmstone Heat Battery' that can be charged by low-cost electricity from the grid, store that electricity for 24 hours and provide it on demand. The second is a 'Heat Interface Unit' (HIU) that replaces the existing boiler. Caldera believes that low electricity prices always tend to occur when the source of electricity is also low carbon. It will use the investment to grow its business across different verticals.
days to go: Expired investment: £615,000
CareGREEN is an innovation company that has created a unique air pollution capture and storage technology with the aim to reduce harmful pollution in the atmosphere. Their latest product is the Environmental Air Purification Intervention & Control System (EAPICS). The technology has been accredited as a significant solution in reducing COx worldwide. A World Health Organisation (2016) report established that more than 80% of people living in urban areas face the greatest environmental risk to their health today due to air pollution. CareGREEN believes its specialised filtration systems will contribute to a considerable fall in health issues linked to poor air quality. It is also diversifying its reach in other renewable energy sectors such as solar and wind. The company will utilise the investment to scale its business.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph